VSee Health Reports 19% Revenue Growth in Q3 2025, Net Loss Improves

VSee Health, Inc. reported its financial results for the third quarter and the nine months ended September 30, 2025, revealing significant changes in revenue and expenses compared to the previous fiscal period. The company generated total revenues of $3.98 million for the third quarter, a 19% increase from $3.35 million in the same period last year. For the nine months, revenues reached $10.69 million, marking a 60% increase from $6.69 million in the prior year. This growth was primarily driven by the acquisition of iDoc, which contributed significantly to both telehealth service volume and patient fees.

Despite the revenue growth, VSee Health experienced a substantial increase in costs. The cost of revenues for the third quarter surged to $1.91 million, up 235% from $569,734 in the prior year, largely due to higher compensation expenses associated with increased utilization of independent medical providers. For the nine-month period, the cost of revenues rose to $5.17 million, a 173% increase compared to $1.89 million in the same period last year. The overall gross margin for the third quarter was $2.07 million, down 26% from $2.78 million in the previous year, while the gross margin for the nine months increased by 15% to $5.52 million.

Operating expenses for VSee Health saw a dramatic decrease, primarily due to the absence of goodwill impairment charges that had significantly impacted the previous year's results. Operating expenses for the third quarter were reported at $4.13 million, a 93% decrease from $61.08 million in the same quarter of 2024. For the nine months, operating expenses totaled $11.67 million, down 82% from $63.92 million in the prior year. The reduction in operating expenses was attributed to the lack of goodwill impairment charges and transaction expenses, which were substantial in the previous year.

The company reported a net loss of $289,745 for the third quarter, a significant improvement compared to a net loss of $53.92 million in the same period last year. For the nine months, the net loss was $6.86 million, down 87% from $54.49 million in the prior year. This improvement in net loss was largely due to the absence of goodwill impairment charges and a reduction in operating expenses, despite an increase in interest expenses and changes in the fair value of financial instruments.

Looking ahead, VSee Health's management expressed optimism about future growth, driven by the ongoing expansion of its telehealth services and the integration of iDoc's capabilities. The company is actively pursuing additional financing to support its working capital needs and growth initiatives, including a $50 million equity line of credit agreement. However, management also acknowledged the challenges posed by ongoing operating losses and liquidity concerns, emphasizing the need for continued strategic execution to enhance revenue generation and operational efficiency.